BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer

Contributed by: Business Wire

Logo

Tags

Biotechnology

General Health

Health

Pharmaceutical

Oncology

BeiGene, Ltd.

More Like This

BeiGene Announces Updates to Commercial Leadership Team

Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors

(Graphic: Business Wire)

BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates

Olivier Brandicourt, M.D. (Photo: Business Wire)

BeiGene Welcomes Experienced Life Sciences Executive Olivier Brandicourt to Board of Directors

BeiGene Mourns Death of Beloved Board Member Donald Glazer

(Graphic: Business Wire)

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer

BeiGene Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

BeiGene's flagship biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J., is seen. (Photo: Business Wire)

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World